Inbound Relationships |
Type |
Active |
Source |
Characteristic |
Refinability |
Group |
Griseofulvin ultramicrosize 250 mg oral tablet |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Griseofulvin ultramicrosize |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Griseofulvin ultramicrosize 165 mg oral tablet |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Griseofulvin ultramicrosize |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Griseofulvin ultramicrosize 330 mg oral tablet |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Griseofulvin ultramicrosize |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Griseofulvin ultramicrosize 125 mg oral tablet |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Griseofulvin ultramicrosize |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Griseofulvin ultramicrosize 125 mg oral tablet |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Griseofulvin ultramicrosize |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
Griseofulvin ultramicrosize 125 mg oral tablet |
Has basis of strength substance (attribute) |
True |
Griseofulvin ultramicrosize |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
Griseofulvin ultramicrosize 165 mg oral tablet |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Griseofulvin ultramicrosize |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
Griseofulvin ultramicrosize 165 mg oral tablet |
Has basis of strength substance (attribute) |
True |
Griseofulvin ultramicrosize |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
Griseofulvin ultramicrosize 330 mg oral tablet |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Griseofulvin ultramicrosize |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
Griseofulvin ultramicrosize 330 mg oral tablet |
Has basis of strength substance (attribute) |
True |
Griseofulvin ultramicrosize |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
Griseofulvin ultramicrosize 250 mg oral tablet |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Griseofulvin ultramicrosize |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
Griseofulvin ultramicrosize 250 mg oral tablet |
Has basis of strength substance (attribute) |
True |
Griseofulvin ultramicrosize |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
Griseofulvin ultramicrosize 125 mg oral tablet |
Has precise active ingredient |
True |
Griseofulvin ultramicrosize |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
Griseofulvin ultramicrosize 250 mg oral tablet |
Has precise active ingredient |
True |
Griseofulvin ultramicrosize |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
Griseofulvin ultramicrosize 165 mg oral tablet |
Has precise active ingredient |
True |
Griseofulvin ultramicrosize |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
Griseofulvin ultramicrosize 330 mg oral tablet |
Has precise active ingredient |
True |
Griseofulvin ultramicrosize |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |